EDGAR·FLOW

Invivyd, Inc. — Form 10-Q

Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 28/100
What the filing says
Invivyd signed employment agreements with Timothy Lee as Chief Commercial Officer (effective June 5, 2024, base salary $420,000/year, 40% target bonus, 600,000 stock options) and Michael Mina as Chief Medical Officer and Chief Epidemiologist (effective July 31, 2026, base salary $535,000/year, 45% target bonus, 1,125,000 stock options plus 375,000 prior grant, $225,000 deferred award). Both agreements include standard severance (9 months base salary if terminated without cause outside change-of-control; 12 months plus target bonus during change-of-control period) and restrictive covenants.
Why this rating

Two C-suite hires are operational but represent ~1.7% and ~2.1% of market cap annually; routine executive hiring for $50.9M company.

View original filing on SEC.gov ↗ IVVD · stock on Yahoo Finance ↗

See more from August 13, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.